Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)
Palo Alto (17 mi)Overseen byJoyce R Gomes Osman, PT, PhD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: University of Miami
No Placebo Group
Approved in 3 jurisdictions
Trial Summary
What is the purpose of this trial?The purpose of this study is to assess the influence of transcranial magnetic stimulation (TMS) on speech performance in individuals with primary progressive apraxia of speech.
Eligibility Criteria
Treatment Details
1Treatment groups
Experimental Treatment
Group I: Transcranial Magnetic Stimulation (TMS)Experimental Treatment1 Intervention
Non-invasive brain stimulation, high frequency repetitive TMS delivered in 10 sessions over a 2-week period.
TMS is already approved in United States, European Union, Canada for the following indications:
🇺🇸 Approved in United States as Transcranial Magnetic Stimulation for:
- Depression
- Anxiety disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
🇪🇺 Approved in European Union as Transcranial Magnetic Stimulation for:
- Depression
- Anxiety disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
🇨🇦 Approved in Canada as Transcranial Magnetic Stimulation for:
- Depression
- Anxiety disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
Find a clinic near you
Research locations nearbySelect from list below to view details:
University of Miami Miller School of MedicineMiami, FL
Loading ...
Who is running the clinical trial?
University of MiamiLead Sponsor